Duo Oncology Announces Key Leadership Team Addition
Dr. Katie Eichinger PharmD, PhD Joins Team as Director of Operations.
PITTSBURGH (PRWEB) January 25, 2022 – Duo Oncology, a life science company developing tumor penetrating nanotherapies, is excited to announce the appointment of Katherine Eichinger, PharmD PhD as Director of Operations. Dr. Eichinger brings over 15 years’ experience in the fields of oncology, immunology, and clinical pharmacy practice to Duo Oncology’s drug development program. As Director of Operations, she will be responsible for driving forward the preclinical development of Duo Oncology’s pipeline of tumor- penetrating nanomedicines and will have a pivotal role in preparing its lead product DUO-207 for future regulatory submissions.
“We are delighted to welcome Dr. Katie Eichinger to the Duo Oncology team at this early stage of the company’s growth,” said Dr Sam Rothstein. “Katie’s years of hands-on experience in preclinical drug development and pharmacy practice will be invaluable as we advance and expand our pipeline.”
“Duo Oncology’s upcoming drug products represent a phenomenal advance in nanomedicine chemistry and hold the potential to address the broad patient population that’s only minimally responsive to current treatments,” said Katie. “I look forward to joining the team at this pivotal time to help prepare this new class of oncology therapeutics for clinical translation and am thrilled that they have the potential to offer real hope to patients suffering from these intractable diseases.”
Katie is a strong scientific leader with a successful track record of preclinical pharmacology research at the University of Pittsburgh and of pharmacy practice in two major hospital systems. Most recently Katie has led a research program at the University of Pittsburgh evaluating protein-based drug products in cancer and autoimmune diseases. This in-depth knowledge of the immune response will be critical in understanding tumor-specific immunity, which is a key mechanistic aspect of lead product DUO-207. During her academic career Katie authored 11 publications garnering over 224 citations. Katie holds a MS in clinical research and a PharmD from the University of Michigan and a PhD in Pharmaceutical Science from the University of Pittsburgh.
